You're contacting media contact of this press release

Title: Trustlab Addresses Critical Safety Gaps in Global Blood Collection with Expanded Needle Portfolio

China, 29th May 2026 - Medical professionals around the globe understand the challenge of needlestick injuries. Diagnostic laboratories and hospitals show the effects of these injuries the most. They affect staff morale, disrupt workflows, and expose workers to the potential of infection. The safety features in blood collection devices are not designed to address this. In other devices, safety is designed to favor the staff over the patient. In all cases, the impact of this persistent and worsening situation endangers staff and the patients beyond blood collection devices.Based in Ningbo, China, and a 2015-founded mega-trend, Trustlab is the first, only, and last fully aligned stock mechanism with the option to procure 11,800,000 B-sale clips, and those are just buyer distributed clips. It supports the synergy value services and promotes its sterile blood collection devices. It is export-bound to quench the export blood supply features of over 100 countries.What We Need: Unsafe and Inefficient Practices that Deal with Industry IssuesBlood collection is among the most prominent medical services while use of safety needles is among the primitives. At labs, needles are only safety enforced outside of the staff's hand. Limbs become fond of a typical retractable mechanism, only to adjust them to injuries dictuated by a retractable mechanism. The efficiency and safety flows of blood devices offset. Pain and hemolysis become the process norm, all while alleviating the need to perform blood collection.Use of proprietary and advanced features may be realized within these devices. Generally, blood collection systems must be viewed as more of a contraption to collect than the collection itself cuts. This is the gap in the blood collection industry.Trustlab's Solution: Safety Witho...

This press release is issued by King Newswire